Clinical Trial Update: Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 safety and efficacy study of Zamtocabtagene Autoleucel (MB-CART2019.1) in pediatric patients with relapsed/refrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Neoplasms

Drugs mentioned

• Zamtocabtagene Autoleucel

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: B-Cell Neoplasm | Phase 2 | Status: RECRUITING